AIM
ADMS

Ada Investment Management’s Adamas Pharmaceuticals ADMS Stock Holding History

Ada Investment Management’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$267K Buy
+9,436
New +$159K 0.18% 235

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CPH
C Partners Holding Zurich, Switzerland $317M AUM 4.76% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ada Investment Management's ADMS Position: Q4 2015 in Review

Ada Investment Management opened a new position in Adamas Pharmaceuticals (ADMS) in Q4 2015: 9,436 shares worth $267K. The stake represents 0.18% of the portfolio and ranks #235 among its holdings.

93 funds tracked by Wall St. Rank hold ADMS as of Q4 2015.

  • Ada Investment Management held 9,436 shares of Adamas Pharmaceuticals worth $267K as of Q4 2015.
  • Adamas Pharmaceuticals was a new Ada Investment Management position in Q4 2015.
  • Adamas Pharmaceuticals made up 0.18% of Ada Investment Management's portfolio in Q4 2015, its #235 holding.
  • 93 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.